Diving Into Data: Fantasy Sports, Digital Signage, and Tariffs

 

On today’s episode of the “Diving Into Data” podcast, we dive into a number of current issues and examine how they can be analyzed through the use of analytics.

Our primary topic today will be the ongoing economic impact of the tariff trade war with China and how a handful of critical data points show that it has impacted both nations. Many people know that this topic has been a hot-button issue for months, but few understand the economic indicators that are being impacted by those activities.

Additionally, it’s September, so that can only mean one thing… Football is back! We dive into some initial impressions from the 2019 season, as well as recap how each of us feels about our fantasy football teams this fall.

Additionally, we are touch on an interesting topic of conversation in the Pro-AV world. Digital signage is all the rage but how can you gauge the effectiveness of those investments? And what emerging technologies could impact the amount of data that companies are able to capture around that signage?

It’s all inside the first episode of Diving Into Data!

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More